IMM 3.51% 27.5¢ immutep limited

Ann: Overall Survival data from ph IIb AIPAC breast cancer trial, page-241

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,323 Posts.
    lightbulb Created with Sketch. 1646
    I just bought another parcel on top of recent additions through SPP and on-market. For those who believe in this company, come Q4 with some good news we anticipate, this is a bargain price (despite x2 my own average) let alone when in 2022 we get some results that are pretty much stamping out our position in the Immuno-oncology. But like we know that will be too late to jump on board at the bargain price. Plus or minus 20% is all the same for those who have their eyes on the prize. Of course I may well be wrong but hey, I am only putting my own money on this and not advising here.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
27.5¢
Change
-0.010(3.51%)
Mkt cap ! $400.0M
Open High Low Value Volume
28.0¢ 28.3¢ 27.0¢ $1.034M 3.758M

Buyers (Bids)

No. Vol. Price($)
12 98156 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 85523 9
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.